295 related articles for article (PubMed ID: 21525193)
1. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans.
Sevastianova K; Kotronen A; Gastaldelli A; Perttilä J; Hakkarainen A; Lundbom J; Suojanen L; Orho-Melander M; Lundbom N; Ferrannini E; Rissanen A; Olkkonen VM; Yki-Järvinen H
Am J Clin Nutr; 2011 Jul; 94(1):104-11. PubMed ID: 21525193
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3.
Lallukka S; Sevastianova K; Perttilä J; Hakkarainen A; Orho-Melander M; Lundbom N; Olkkonen VM; Yki-Järvinen H
Diabetologia; 2013 Apr; 56(4):886-92. PubMed ID: 23334462
[TBL] [Abstract][Full Text] [Related]
3. Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans.
Lallukka S; Luukkonen PK; Zhou Y; Isokuortti E; Leivonen M; Juuti A; Hakkarainen A; Orho-Melander M; Lundbom N; Olkkonen VM; Lassila R; Yki-Järvinen H
Thromb Haemost; 2017 Jan; 117(2):286-294. PubMed ID: 27929200
[TBL] [Abstract][Full Text] [Related]
4. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.
Kantartzis K; Peter A; Machicao F; Machann J; Wagner S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
Diabetes; 2009 Nov; 58(11):2616-23. PubMed ID: 19651814
[TBL] [Abstract][Full Text] [Related]
5. The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients.
Luukkonen PK; Qadri S; Lehtimäki TE; Juuti A; Sammalkorpi H; Penttilä AK; Hakkarainen A; Orho-Melander M; Arola J; Yki-Järvinen H
J Clin Endocrinol Metab; 2021 Jan; 106(1):e300-e315. PubMed ID: 33064150
[TBL] [Abstract][Full Text] [Related]
6. Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2.
Zhou Y; Llauradó G; Orešič M; Hyötyläinen T; Orho-Melander M; Yki-Järvinen H
J Hepatol; 2015 Mar; 62(3):657-63. PubMed ID: 25457209
[TBL] [Abstract][Full Text] [Related]
7. The PNPLA3-I148M variant increases polyunsaturated triglycerides in human adipose tissue.
Qadri S; Lallukka-Brück S; Luukkonen PK; Zhou Y; Gastaldelli A; Orho-Melander M; Sammalkorpi H; Juuti A; Penttilä AK; Perttilä J; Hakkarainen A; Lehtimäki TE; Orešič M; Hyötyläinen T; Hodson L; Olkkonen VM; Yki-Järvinen H
Liver Int; 2020 Sep; 40(9):2128-2138. PubMed ID: 32386450
[TBL] [Abstract][Full Text] [Related]
8. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans.
Kotronen A; Johansson LE; Johansson LM; Roos C; Westerbacka J; Hamsten A; Bergholm R; Arkkila P; Arola J; Kiviluoto T; Fisher RM; Ehrenborg E; Orho-Melander M; Ridderstråle M; Groop L; Yki-Järvinen H
Diabetologia; 2009 Jun; 52(6):1056-60. PubMed ID: 19224197
[TBL] [Abstract][Full Text] [Related]
9. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
Krawczyk M; Jiménez-Agüero R; Alustiza JM; Emparanza JI; Perugorria MJ; Bujanda L; Lammert F; Banales JM
Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208
[TBL] [Abstract][Full Text] [Related]
10. Weight loss induced by bariatric surgery restores adipose tissue PNPLA3 expression.
Wieser V; Adolph TE; Enrich B; Moser P; Moschen AR; Tilg H
Liver Int; 2017 Feb; 37(2):299-306. PubMed ID: 27514759
[TBL] [Abstract][Full Text] [Related]
11. Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity.
Hyysalo J; Gopalacharyulu P; Bian H; Hyötyläinen T; Leivonen M; Jaser N; Juuti A; Honka MJ; Nuutila P; Olkkonen VM; Oresic M; Yki-Järvinen H
Diabetes; 2014 Jan; 63(1):312-22. PubMed ID: 24009255
[TBL] [Abstract][Full Text] [Related]
12. Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans.
Sevastianova K; Santos A; Kotronen A; Hakkarainen A; Makkonen J; Silander K; Peltonen M; Romeo S; Lundbom J; Lundbom N; Olkkonen VM; Gylling H; Fielding BA; Rissanen A; Yki-Järvinen H
Am J Clin Nutr; 2012 Oct; 96(4):727-34. PubMed ID: 22952180
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible Explanation.
Franko A; Merkel D; Kovarova M; Hoene M; Jaghutriz BA; Heni M; Königsrainer A; Papan C; Lehr S; Häring HU; Peter A
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227635
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.
Hyysalo J; Stojkovic I; Kotronen A; Hakkarainen A; Sevastianova K; Makkonen J; Lundbom N; Rissanen A; Krauss RM; Melander O; Orho-Melander M; Yki-Järvinen H
J Gastroenterol Hepatol; 2012 May; 27(5):951-6. PubMed ID: 22141340
[TBL] [Abstract][Full Text] [Related]
15. The Genetic Variant I148M in PNPLA3 Is Associated With Increased Hepatic Retinyl-Palmitate Storage in Humans.
Kovarova M; Königsrainer I; Königsrainer A; Machicao F; Häring HU; Schleicher E; Peter A
J Clin Endocrinol Metab; 2015 Dec; 100(12):E1568-74. PubMed ID: 26439088
[TBL] [Abstract][Full Text] [Related]
16. The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes.
Xia MF; Lin HD; Chen LY; Wu L; Ma H; Li Q; Aleteng Q; Hu Y; He WY; Gao J; Bian H; Li XY; Gao X
Diabetologia; 2019 Apr; 62(4):644-654. PubMed ID: 30673802
[TBL] [Abstract][Full Text] [Related]
17. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents.
Santoro N; Kursawe R; D'Adamo E; Dykas DJ; Zhang CK; Bale AE; Calí AM; Narayan D; Shaw MM; Pierpont B; Savoye M; Lartaud D; Eldrich S; Cushman SW; Zhao H; Shulman GI; Caprio S
Hepatology; 2010 Oct; 52(4):1281-90. PubMed ID: 20803499
[TBL] [Abstract][Full Text] [Related]
18. PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease.
Sookoian S; Pirola CJ
World J Gastroenterol; 2012 Nov; 18(42):6018-26. PubMed ID: 23155331
[TBL] [Abstract][Full Text] [Related]
19. I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.
Xia MF; Ling Y; Bian H; Lin HD; Yan HM; Chang XX; Li XM; Ma H; Wang D; Zhang LS; Wang SS; Wu BJ; He WY; Zhao NQ; Gao X
Aliment Pharmacol Ther; 2016 Mar; 43(5):631-42. PubMed ID: 26765961
[TBL] [Abstract][Full Text] [Related]
20. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.
Pirazzi C; Adiels M; Burza MA; Mancina RM; Levin M; Ståhlman M; Taskinen MR; Orho-Melander M; Perman J; Pujia A; Andersson L; Maglio C; Montalcini T; Wiklund O; Borén J; Romeo S
J Hepatol; 2012 Dec; 57(6):1276-82. PubMed ID: 22878467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
